- Home
- PCRX vs EE Comparison
PCRX vs EE Comparison
Compare PCRX & EE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCRX
- EE
- Stock Information
- Founded
- PCRX 2006
- EE 2003
- Country
- PCRX United States
- EE United States
- Employees
- PCRX N/A
- EE N/A
- Industry
- PCRX Biotechnology: Pharmaceutical Preparations
- EE Oil/Gas Transmission
- Sector
- PCRX Health Care
- EE Utilities
- Exchange
- PCRX Nasdaq
- EE Nasdaq
- Market Cap
- PCRX 1.2B
- EE 914.5M
- IPO Year
- PCRX 2011
- EE 2022
- Fundamental
- Price
- PCRX $23.22
- EE $27.94
- Analyst Decision
- PCRX Buy
- EE Hold
- Analyst Count
- PCRX 8
- EE 7
- Target Price
- PCRX $28.38
- EE $32.29
- AVG Volume (30 Days)
- PCRX 569.8K
- EE 453.2K
- Earning Date
- PCRX 07-29-2025
- EE 08-06-2025
- Dividend Yield
- PCRX N/A
- EE 0.83%
- EPS Growth
- PCRX N/A
- EE 37.63
- EPS
- PCRX N/A
- EE 1.53
- Revenue
- PCRX $702,772,000.00
- EE $966,414,000.00
- Revenue This Year
- PCRX $7.54
- EE $34.48
- Revenue Next Year
- PCRX $10.78
- EE $14.93
- P/E Ratio
- PCRX N/A
- EE $18.95
- Revenue Growth
- PCRX 3.08
- EE N/A
- 52 Week Low
- PCRX $11.16
- EE $17.54
- 52 Week High
- PCRX $27.64
- EE $32.99
- Technical
- Relative Strength Index (RSI)
- PCRX 35.42
- EE 46.71
- Support Level
- PCRX $22.82
- EE $27.78
- Resistance Level
- PCRX $24.36
- EE $29.98
- Average True Range (ATR)
- PCRX 0.69
- EE 0.86
- MACD
- PCRX -0.12
- EE -0.20
- Stochastic Oscillator
- PCRX 17.09
- EE 33.82
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
About EE Excelerate Energy Inc.
Excelerate Energy Inc offers LNG solutions, providing integrated services along the LNG value chain. It offers a full range of regasification services, from FSRUs to infrastructure development, to LNG and natural gas supply. Its business spans the globe, with a regional presence in 11 countries and an operational presence in Argentina, Bangladesh, Brazil, Finland, Germany, Pakistan, the United Arab Emirates (UAE), and the United States.